Clinical aspects of augmentation enterocystoplasties

Area of Science:

• Urology
• Surgical Oncology

Background:

• Cystitis, including tuberculous, interstitial, radiation, and chronic bacterial forms, presents significant challenges in bladder management.
• Hypertonic neurogenic bladder requires effective treatment strategies to improve quality of life.

Purpose of the Study:

• To evaluate the efficacy of augmentation enterocystoplasty in patients with various forms of refractory cystitis and neurogenic bladder.
• To identify factors influencing surgical outcomes and determine the optimal bowel segment for augmentation.

Main Methods:

• Augmentation enterocystoplasty was performed in 28 patients.
• Patient outcomes were assessed, considering bladder pathology, extent of resection, and bowel segment used (ileocecal preferred for non-tuberculous forms).
• Radiographic, urodynamic, and radioisotope scan studies were utilized for follow-up.

Main Results:

• Successful outcomes were observed in tuberculous contracted bladders, independent of resection extent or bowel segment.
• The ileocecal segment demonstrated preference in other cystitis forms.
• Patients with neurogenic bladder did not experience benefits from the procedure.
• Various causes of surgical failure were identified and discussed.

Conclusions:

• Augmentation enterocystoplasty is effective for select cases of refractory cystitis, particularly tuberculous contracted bladders.
• The ileocecal segment is recommended for augmentation in most non-tuberculous cystitis.
• This procedure is not indicated for hypertonic neurogenic bladder.
• Pharmacologic therapy and further bladder neck surgery may address partial surgical failures.